Mr. Wehrwein has served as a director of our company since June 2011 and serves as chair of the Audit Committee and as a member of the Nominating and Governance Committee. Mr. Wehrwein has been an independent financial consultant to emerging companies since 1999. He has more than 35 years of experience as an investment banker, chief financial officer and certified public accountant (inactive). He currently serves on the board of directors of Atricure, Inc., a medical device company and SPS Commerce, Inc., a supply-chain management software company, both of which are publicly-traded companies.
Mr. Wehrwein also served on the board of directors for the following publicly-traded companies: Compellent Technologies, Inc. from 2007 until its acquisition by Dell Inc. in 2011; Vital Images, Inc. from 1997 until its acquisition by Toshiba Medical Systems Corp. in 2011; Synovis Life Technologies, Inc. from 2004 until its acquisition by Baxter International Inc. in 2012; Cogentix Medical, Inc., a medical device company, from 2006 to 2016; and Image Sensing Systems, Inc., a vehicle detection software company, from 2006-2012.
Mr. Wehrwein’s qualifications to serve on our board of directors include, among other skills and qualifications, his capabilities in financial understanding, strategic planning and auditing expertise, given his experiences in investment banking and in financial leadership positions. As chairman of the Audit Committee, Mr. Wehrwein also keeps the board abreast of current audit issues and collaborates with our independent auditors and senior management team.
What is Sven Wehrwein's net worth?
The estimated net worth of Sven Wehrwein is at least $2.43 million as of June 2nd, 2026. Mr. Wehrwein owns 32,505 shares of Proto Labs stock worth more than $2,434,202 as of June 5th. This net worth approximation does not reflect any other assets that Mr. Wehrwein may own. Learn More about Sven Wehrwein's net worth.
How do I contact Sven Wehrwein?
Has Sven Wehrwein been buying or selling shares of Proto Labs?
During the past quarter, Sven Wehrwein has sold $154,560.00 of Proto Labs stock. Most recently, Sven Wehrwein sold 2,000 shares of the business's stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a transaction totalling $154,560.00. Following the completion of the sale, the director now directly owns 32,505 shares of the company's stock, valued at $2,511,986.40. Learn More on Sven Wehrwein's trading history.
Who are Proto Labs' active insiders?
Are insiders buying or selling shares of Proto Labs?
During the last year, Proto Labs insiders bought shares 1 times. They purchased a total of 1,725 shares worth more than $75,054.75. During the last year, insiders at the industrial products company sold shares 6 times. They sold a total of 31,211 shares worth more than $2,107,645.44. The most recent insider tranaction occured on June, 2nd when Director Sven Wehrwein sold 2,000 shares worth more than $154,560.00. Insiders at Proto Labs own 1.3% of the company.
Learn More about insider trades at Proto Labs. Information on this page was last updated on 6/2/2026.
